A paediatric extension extends the lifetime of a supplementary protection certificate (SPC) on a medicinal product by a further six months where an application for a marketing authorisation on the product includes the results of all studies performed and details of all information collected in compliance with an agreed paediatric investigation plan (PIP . . .
This content is restricted to subscribers. To view this content please register an account.
If you are already a subscriber, please login below.